共 50 条
- [41] Monitoring T315I mutation in chronic myeloid leukemia by amplification refractory mutation system PCRREVISTA ROMANA DE MEDICINA DE LABORATOR, 2008, 13 (04): : 17 - 20Dima, DeliaTrifa, Adrian P.Cucuianu, AndreiPopp, Radu A.Patiu, MarianaPetrov, Ljubomir
- [42] The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinibLeukemia, 2006, 20 : 650 - 657C MiethingS FeihlC MuglerR GrundlerN von BubnoffF LordickC PeschelJ Duyster
- [43] Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case reportPHARMACOGENOMICS, 2015, 16 (07) : 677 - 679Venton, GeoffroyColle, JulienMercier, CedricFanciullino, RaphaelleCiccolini, JosephIvanov, VadimSuchon, PierreSebahoun, GerardBeaufils, NathalieGabert, JeanHadjaj, DjamalCostello, Regis
- [44] The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinibLEUKEMIA, 2006, 20 (04) : 650 - 657Miething, CFeihl, SMugler, CGrundler, Rvon Bubnoff, NLordick, FPeschel, CDuyster, J
- [45] Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatmentLEUKEMIA, 2015, 29 (01) : 230 - 232Yeung, D. T.Moulton, D. J.Heatley, S. L.Nievergall, E.Dang, P.Braley, J.Branford, S.Moore, S.Mullighan, C. G.Hughes, T. P.White, D. L.
- [46] HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt–autophagy pathwayHuman Cell, 2023, 36 : 1564 - 1577Le YinQingyang ZhangSisi XieZhao ChengRuijuan LiHongkai ZhuQian YuHuan YuanCanfei WangHongling PengGuangsen Zhang
- [47] Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemiaCANCER LETTERS, 2020, 472 : 132 - 141Gupta, PranavZhang, Guan-NanBarbuti, Anna MariaZhang, XinKaradkhelkar, NishantZhou, JingfengDing, KePan, JingxuanYoganathan, SabesanYang, Dong-HuaChen, Zhe-Sheng
- [48] Detection of BCR-ABL T315i Mutation in Imatinib Resistant Chronic Myeloid Leukemia PatientsMEDICINE AND HEALTH-KUALA LUMPUR, 2019, 14 (01): : 145 - 156Mardziah, M.Salwati, S.Azlin, IHafiza, A.Farisah, Noor A. R.Noraesah, M.Tumian, N. R.Wong, C. L.Azma, R. Z.
- [49] Discovery of New Benzothiazole-Based Inhibitors of Breakpoint Cluster Region-Abelson Kinase Including the T315I MutantJOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (09) : 3531 - 3545Hong, SeungheeKim, JinheeYun, Sun-MiLee, HyunseungPark, YoonsuHong, Soon-SunHong, Sungwoo
- [50] A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutantBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (15) : 3436 - 3440Radi, MarcoSchneider, RalfFallacara, Anna LuciaBotta, LorenzoCrespan, EmmanueleTintori, CristinaMaga, GiovanniKissova, MiroslavaCalgani, AlessiaRichters, AndreMusumeci, FranescaRauh, DanielSchenone, Silvia